BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23242962)

  • 1. Abscesses and wound infections due to Staphylococcus lugdunensis: report of 16 cases.
    Papapetropoulos N; Papapetropoulou M; Vantarakis A
    Infection; 2013 Apr; 41(2):525-8. PubMed ID: 23242962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and antimicrobial susceptibility of Staphylococcus lugdunensis in a Greek tertiary-care hospital.
    Kachrimanidou M; Malliou P; Meletis G; Netsika F; Mavrovouniotis I; Protonotariou E; Skoura L
    New Microbiol; 2020 Jul; 43(3):133-135. PubMed ID: 32596739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases.
    Arias M; Tena D; Apellániz M; Asensio MP; Caballero P; Hernández C; Tejedor F; Bisquert J
    Scand J Infect Dis; 2010 Dec; 42(11-12):879-84. PubMed ID: 20735327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.
    Frank KL; Del Pozo JL; Patel R
    Clin Microbiol Rev; 2008 Jan; 21(1):111-33. PubMed ID: 18202439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
    Lozano-Masdemont B; Gómez-Recuero-Muñoz L; Pulido-Pérez A
    Actas Dermosifiliogr; 2015 Nov; 106(9):769-70. PubMed ID: 26076877
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.
    Farrell DJ; Mendes RE; Bensaci M
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):85-88. PubMed ID: 30314652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and microbiological properties of Staphylococcus lugdunensis skin infections.
    Zaaroura H; Geffen Y; Bergman R; Avitan-Hersh E
    J Dermatol; 2018 Aug; 45(8):994-999. PubMed ID: 29897142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Staphylococcus lugdunensis infection: report of 44 cases].
    Betrán A; Cebollada R; Lavilla MJ; Torres L
    Rev Chilena Infectol; 2022 Jun; 39(3):254-259. PubMed ID: 36156686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.
    Natsis NE; Cohen PR
    Am J Clin Dermatol; 2018 Oct; 19(5):671-677. PubMed ID: 29882122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.
    McHardy IH; Veltman J; Hindler J; Bruxvoort K; Carvalho MM; Humphries RM
    J Clin Microbiol; 2017 Feb; 55(2):585-595. PubMed ID: 27927926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of methicillin resistant
    Upreti N; Rayamajhee B; Sherchan SP; Choudhari MK; Banjara MR
    Antimicrob Resist Infect Control; 2018; 7():121. PubMed ID: 30338059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Staphylococcus lugdunensis infection: Report of thirteen cases].
    Sánchez P; Buezas V; Maestre JR
    Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):475-8. PubMed ID: 11844452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary lung abscess caused by Staphylococcus lugdunensis.
    Chou DW; Lee CT
    J Infect Chemother; 2017 Nov; 23(11):791-793. PubMed ID: 28751155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
    Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
    J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of
    Hurvitz N; Cahan LOS; Gross I; Grupel D; Megged O; Pasternak Y; Temper V; Levy R; Weiser G; Hashavya S
    J Med Microbiol; 2021 May; 70(5):. PubMed ID: 34038340
    [No Abstract]   [Full Text] [Related]  

  • 16. Virulence factors among Staphylococcus lugdunensis are associated with infection sites and clonal spread.
    Giormezis N; Kolonitsiou F; Makri A; Vogiatzi A; Christofidou M; Anastassiou ED; Spiliopoulou I
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):773-8. PubMed ID: 25471196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of oxacillin-resistant Staphylococcus lugdunensis carrying staphylococcal cassette chromosome mec type V in central Taiwan.
    Yen TY; Sung YJ; Lin HC; Peng CT; Tien N; Hwang KP; Lu JJ
    J Microbiol Immunol Infect; 2016 Dec; 49(6):885-891. PubMed ID: 25648670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
    Liang M; Mansell C; Wade C; Fisher R; Devlin G
    N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infection by Staphylococcus lugdunensis: clinico-microbiologic characterization of 25 cases].
    Ros MJ; Ramírez A; Arteaga E; Alberto C; Gil J; Reina J
    Enferm Infecc Microbiol Clin; 1999 May; 17(5):223-6. PubMed ID: 10396086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options.
    Taha L; Stegger M; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1449-1455. PubMed ID: 31144243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.